2023
DOI: 10.21203/rs.3.rs-2742084/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Immune-related cystitis due to immune checkpoint inhibitors: a case report

Abstract: Background:Immune checkpoint inhibitors (ICIs) have been proven to be beneficial in multiple advanced malignancies. However, the widespread use of ICIs also occurred with various immune-related adverse events (irAEs). However, while various immune-related adverse events related to immune checkpoint inhibitors have been reported, there are few reports of lower urinary tract symptoms. Case presentation:A 42-year-old woman with lung cancer who was being treated with sintilimab, anlotinib, and denosumab presented … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 6 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?